Quantcast
Channel: cafepharma - MedImmune
Browsing latest articles
Browse All 23 View Live
↧

News

:0
:0
October 31, 2010, 8:35 am

Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships Seeking Alpha

View Article
Search

News

:0
:0
December 3, 2010, 5:24 am

Pharma Mergers Scrutinized In Insider Trading Probe Reuters

View Article

News

:0
:0
December 16, 2010, 10:11 am

MedImmune inks $342M collaboration on diabetes program Fierce Biotech

View Article

News

:0
:0
January 11, 2011, 11:36 am

PDLI's Synagis Lawsuit Invalidated Yahoo/Zacks.com

View Article

News

:0
:0
February 18, 2011, 12:17 pm

PDL Settles MedImmune Dispute Yahoo/Zacks.com

View Article

AstraZeneca unit loses patent rights

:0
:0
July 6, 2011, 5:17 am

AstraZeneca unit loses patent rights FT.com

View Article

MedImmune begins shipping influenza vaccine

:0
:0
July 18, 2011, 10:45 am

MedImmune begins shipping influenza vaccine Yahoo/AP

View Article

MedImmune sues Abbott over drug development deal

:0
:0
August 22, 2011, 3:02 pm

MedImmune sues Abbott over drug development deal Bizjournals.com

View Article
Search

MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer

:0
:0
October 3, 2011, 7:39 am

MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer Yahoo

View Article

Was MedImmune worth $15.6 billion?

:0
:0
August 6, 2012, 8:44 am

Was MedImmune worth $15.6 billion? Washington Post, DC

View Article

AstraZeneca's MedImmune in China joint venture to develop inflammatory...

:0
:0
September 11, 2012, 7:41 am

AstraZeneca's MedImmune in China joint venture to develop inflammatory disease drug Yahoo/AP

View Article

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture

:0
:0
September 16, 2012, 8:40 am

China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture Seeking Alpha

View Article

MedImmune partners on trials for a new slate of cancer immunotherapy combos

:0
:0
October 10, 2012, 9:00 am

MedImmune partners on trials for a new slate of cancer immunotherapy combos Fierce Biotech

View Article

AstraZeneca's MedImmune unit acquires AlphaCore Pharma

:0
:0
April 3, 2013, 5:37 am

AstraZeneca's MedImmune unit acquires AlphaCore Pharma Yahoo/Fly on the Wall

View Article

MedImmune chief taps top prospects, hunts new biologics deals

:0
:0
April 29, 2013, 10:00 am

MedImmune chief taps top prospects, hunts new biologics deals Fierce Biotech

View Article
Search

AstraZeneca forges $500M cancer-combo tech buyout for MedImmune

:0
:0
August 26, 2013, 6:34 am

AstraZeneca forges $500M cancer-combo tech buyout for MedImmune Fierce Biotech

View Article

AstraZeneca to Pay Up to $440 Million for Spirogen

:0
:0
October 15, 2013, 6:39 am

AstraZeneca to Pay Up to $440 Million for Spirogen Bloomberg

View Article

AstraZeneca raises bet on cancer immunotherapy with Immunocore deal

:0
:0
January 8, 2014, 5:09 am

AstraZeneca raises bet on cancer immunotherapy with Immunocore deal Yahoo/Reuters

View Article

Deals Of The Week: UCSF Catalyzes R&D Tech-Transfer Deals With Private Sector

:0
:0
February 14, 2014, 10:06 am

Deals Of The Week: UCSF Catalyzes R&D Tech-Transfer Deals With Private Sector In Vivo Blog

View Article

AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints

:0
:0
May 12, 2014, 8:51 am

AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints The Fly on the Wall

View Article
Browsing latest articles
Browse All 23 View Live
Search